total
cf
patient
girl
boy
median
age
year
age
rang
year
enrol
studi
septemb
septemb
nasopharyng
aspir
nasal
mucu
specimen
viral
investig
well
sputum
oropharyng
sampl
microbiolog
cultur
collect
schedul
visit
unschedul
visit
occas
median
sd
visit
per
patient
rang
visit
clinic
lung
function
data
obtain
visit
exacerb
respiratori
diseas
defin
presenc
follow
sign
symptom
fever
increas
amount
secret
cough
intens
chang
sputum
color
worsen
dyspnea
loss
appetit
decreas
forc
expiratori
volum
weight
loss
total
nucleic
acid
extract
nasopharyng
sampl
use
qiamp
viral
rna
mini
kit
qiagen
hamburg
germani
accord
manufactur
instruct
revers
transcript
conduct
high
capac
cdna
archiv
kit
appli
biosystem
foster
citi
ca
usa
use
previous
extract
rna
respiratori
virus
identifi
individu
revers
pcr
select
rsv
influenza
virus
b
human
parainfluenza
virus
human
coronaviru
human
metapneumoviru
adenoviru
human
bocaviru
picornaviru
gene
picornaviru
use
primer
pair
includ
portion
noncod
region
ncr
common
picornavirus
condit
previous
describ
sequenc
amplif
product
examin
capillari
electrophoresi
autom
dna
sequenc
megabac
gener
electr
bioscienc
littl
chalfont
uk
result
visual
megabac
fragmentprofil
softwar
discrimin
fragment
size
fluoresc
intens
sampl
picornaviru
cdna
identifi
submit
taqmanbas
realtim
pcr
protocol
identifi
hrv
enteroviru
sampl
rhinoviru
identifi
realtim
pcr
submit
sequenc
abi
autom
sequenc
appli
biosystem
result
submit
genbank
databas
access
no
sequenc
ncr
region
shown
accur
discrimin
among
subtyp
rhinoviru
includ
genotyp
c
sequenc
chromatogram
obtain
edit
manual
obtain
contigu
fragment
contig
use
sequenc
navig
softwar
appli
biosystem
sequenc
screen
nation
center
biotechnolog
inform
websit
use
basic
local
align
search
tool
blast
http
blastncbinlmnihgovblastcgi
hrv
genotyp
confirm
phylogenet
analysi
describ
sequenc
gener
set
refer
strain
repres
hrv
genotyp
avail
genbank
databas
align
use
clustalw
minor
manual
adjust
made
improv
align
bioedit
softwar
wwwmbioncsuedubioeditbioedithtml
sequenc
echoviru
use
outgroup
phylogenet
analysi
perform
paup
version
http
paupcsitfsuedu
neighborjoin
maximumlikelihood
tree
construct
basi
appropri
nucleotid
substitut
model
determin
modeltest
univers
vigo
vigo
spain
bootstrap
assess
use
replic
tree
visual
use
treeview
program
wwwtaxonomyzoologyglaacukrodtreeviewhtml
account
correl
among
sampl
patient
use
binomi
gener
linear
model
identifi
virolog
variabl
associ
main
endpoint
respiratori
exacerb
hospit
admiss
result
present
odd
ratio
or
confid
interv
least
respiratori
viru
identifi
sampl
rhinoviru
main
identifi
agent
sampl
result
viru
identif
relat
clinic
statu
shown
tabl
coinfect
found
sampl
rhinoviru
frequent
agent
sequenc
perform
sampl
posit
rhinoviru
show
predomin
genotyp
sampl
figur
rhinoviru
subtyp
c
identifi
sampl
isol
sampl
identifi
coxsackieviru
echoviru
therefor
isol
enterovirus
indic
realtim
pcr
platform
misidentifi
sequenc
success
sampl
maximumlikelihood
phylogenet
tree
sampl
refer
hrv
sequenc
construct
figur
patient
examin
acut
exacerb
respiratori
diseas
occas
patient
requir
hospit
admiss
occas
identif
respiratori
virus
associ
pulmonari
exacerb
rhinoviru
main
agent
identifi
among
stabl
patient
verifi
effect
respiratori
virus
exclud
rhinoviru
analysi
signific
associ
respiratori
exacerb
found
p
tabl
contrast
look
rhinoviru
subtyp
notic
identif
rhinoviru
subtyp
c
also
significantli
associ
respiratori
exacerb
tabl
identif
influenza
variabl
associ
increas
risk
hospit
admiss
confid
interv
p
new
hrv
genotyp
initi
describ
sampl
patient
influenzalik
ill
recent
evid
increas
involv
hrvc
sever
respiratori
condit
bronchiol
infant
exacerb
asthma
howev
studi
attempt
clarifi
pathogen
new
speci
includ
control
group
nonsymptomat
person
studi
report
obtain
sampl
patient
routin
visit
exacerb
enabl
us
identifi
distinct
role
differ
hrv
subtyp
find
howev
extrapol
infant
cf
underrepres
studi
infant
may
greater
risk
hrvc
respiratori
infect
rsv
infect
previou
studi
respiratori
viru
infect
cf
patient
provid
conflict
result
potenti
effect
rhinoviru
smyth
et
al
evalu
respiratori
exacerb
cf
patient
identifi
rhinoviru
lead
agent
exacerb
follow
benign
cours
result
greater
use
intraven
antimicrobi
drug
olesen
et
al
studi
cf
patient
year
use
pcr
investig
presenc
differ
virus
sputum
laryng
aspir
group
report
viral
infect
reduc
lung
function
increas
respiratori
symptom
rhinoviru
far
lead
agent
identifi
throughout
studi
recent
studi
wat
et
al
use
realtim
nucleic
acid
amplif
conjunct
molecular
marker
investig
presenc
respiratori
virus
children
cf
describ
associ
viral
infect
respiratori
exacerb
particularli
caus
influenza
influenza
b
rhinoviru
report
infect
novel
rhinoviru
subtyp
c
cf
patient
signific
associ
found
presenc
agent
respiratori
exacerb
find
indic
need
investig
hrvc
cf
patient
